MAMargareth Zuluaga Aricapa

Margareth Zuluaga Aricapa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Margareth Zuluaga Aricapa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Profile of Priority Antimicrobial-Resistant Pathogens and the Behavior of Multidrug-Resistant Tuberculosis in the Santiago de Cali District, Colombia

    by Alejandra Mondragón Quiguanas, Jorge Iván Montoya Salazar, Juan Camilo Mosquera-Hernandez, Margareth Zuluaga Aricapa, Carlos Eduardo Pinzón Flórez, German Escobar Morales, Johana Alejandra Moreno-Drada, Bruno Gutiérrez, Lucy Marcela Díaz Rivadeneira

    Background: Antimicrobial resistance is a threat that increases morbidity and mortality. This cross-sectional study aimed to describe the profile of priority antimicrobial-resistant pathogens and to analyze the behavior of multidrug-resistant tuberculosis (MDR-TB) in the Santiago de Cali District, Colombia. Methods: researchers compiled information from data provided by healthcare institutions, the National Public Health Surveillance System, and laboratory-based surveillance using the World Health Organization’s WHONET v.5.6 software. Univariate statistical analysis described trends in pathogen resistance, and multivariate analysis analyzed the behavior of MDR-TB. Results: Among Gram-negative bacteria, high levels of carbapenem resistance were observed in A. baumannii (84% aztreonam resistance) and in K. pneumoniae (63%). P. aeruginosa exhibited elevated multidrug resistance, consistent with extensive antimicrobial selective pressure. MDR-TB exhibited a high burden of resistance, reaching 96%, with projections indicating a potential increase driven by monoresistance and resistance to rifampicin. Patients with drug-resistant tuberculosis who were HIV-positive or experiencing homelessness had a significantly higher likelihood of hospitalization (OR 5.59; 95% CI 3.09–10.11 and OR 2.94; 95% CI 1.48–5.81, respectively) and mortality (OR 3.34; 95% CI 1.72–6.49 and OR 2.59; 95% CI 1.16–5.79, respectively). Conclusions: The expansion of resistance mechanisms suggests sustained selective pressure, underscoring the need for strategies to optimize antibiotics.


  • Open Access

    Brote por Ralstonia insidiosa, en tres sedes de una institución de salud, Cali, Colombia, 2022

    by Margareth Zuluaga Aricapa, Stella Murillo de Apraez, Silvio Duque

    Antecedentes: El 18 de mayo de 2022, la secretaría de salud distrital de Cali recibió una alerta de una IPS de nivel IV que notificó aislamiento de Ralstonia insidiosa en hemocultivos de cinco pacientes con bacteriemia, hospitalizados en tres sedes de dicha IPS, en un período de cuatro días. Desde el año 2013, la IPS no reportaba casos con este microorganismo y, dado el aumento inusitado del microorganismo, se confirmó el brote y se procedió a orientar la investigación epidemiológica para la trazabilidad de los medicamentos administrados e identificar fuente